IMA FY 2024 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-61.8% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$37M-1057.1% margin

Net Income

-$37M-1044.8% margin

EPS (Diluted)

$-1.02

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$142M

Total Liabilities

$16M

Stockholders' Equity

$126M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$9M	-61.8%
Gross Profit	$4M	$8M	-57.0%
Operating Income	-$37M	-$75M	+50.9%
Net Income	-$37M	-$68M	+46.4%